Table 2. Frequencies of allelic variants in the Chinese renal transplant recipients.

Genotypes (n,%)	Days 1 to14	Stable condition
	N = 240	N = 183
CYP3A5 (*1/*1, *1/*3, *3/*3)	21/103/116	17/81/85
	(8.75%,42.92%,48.33%)	(9.29%,44.26%,46.45%)
CYP3A5 rs28365085 T>C (T/T, T/C, C/C)	240/0/0	183/0/0
	(100%,0%,0%)	(100%,0%,0%)
CYP3A4 (*1/*1, *1/*1G, *1G/*1G)	131/90/19	98/73/12
	(54.58%,37.50%,7.92%)	(53.55%, 39.89%, 6.56%)
CYP3A4 rs4646437 T>C (T/T, T/C, C/C)	10/80/150	6/63/114
	(4.17%,33.33%,62.50%)	(3.28%,34.42%,62.30%)
CYP3A4 (*1/*1,*1/*22, *22/*22)	240/0/0	183/0/0
	(100%,0%,0%)	(100%,0%,0%)
CYP3A4 rs33972239 delT (−/−, −/T, T/T)	240/0/0	183/0/0
	(100%,0%,0%)	(100%,0%,0%)
POR rs1057868 C>T (C/C, C/T, T/T)	101/107/32	67/90/26
	(42.08%,44.58%,13.34%)	(36.61%,49.18%,14.21%)
POR rs2868177 A>G (A/A, A/G, G/G)	84/104/52	65/85/33
	(35.00%, 43.33%,21.67%)	(35.52%,46.45%,18.03%)
COMT rs4646312 T>C (T/T, T/C, C/C)	115/98/27	92/73/18
	(47.92%, 40.83%, 11.25%)	(50.27%,39.89%,9.84%)
COMT rs2239393 A>G (A/A, A/G, G/G)	116/96/28	93/71/19
	(48.33%, 40.00%, 11.67%)	(50.82%,38.80%,10.38%)
COMT rs737865 T>C (T/T, T/C, C/C)	126/92/22	99/70/14
	(52.50%,38.33%, 9.17%)	(54.10%,38.25%,7.65%)
COMT rs6267 G>T (G/G, G/T, T/T)	213/26/1	163/19/1
	(88.75%,10.83%, 0.42%)	(89.07%,10.38%,0.55%)
COMT rs4680 G>A (G/G, G/A, A/A)	133/86/21	97/69/17
	(55.42%, 35.83%, 8.75%)	(53.01%,37.70%,9.29%)
COMT rs165599 G>A (G/G, G/A, A/A)	54/138/48	38/106/39
	(22.50%, 57.50%, 20.00%)	(20.77%,57.92%,21.31%)
IL-10 rs1800871 C>T (C/C, C/T, T/T)	15/111/114	8/84/91
	(6.25%, 46.25%, 47.50%)	(4.37%,45.90%,49.73%)
IL-10 rs1800896 A>G (A/A, A/G, G/G)	217/23/0	168/15/0
	(90.42%, 9.58%, 0%)	(91.80%,8.20%,0%)
IL-10 rs1800872 C>A (C/C, C/A, A/A)	15/112/113	8/85/90
	(6.25%, 46.67%, 47.08%)	(4.37%,46.45%,49.18%)